HOME
ABOUT MORSE
The Team
Strategic Partners
Lorraine Boyle
Dominika Dabrowski
Stephen Filbey
Brent Korte
Careers
SERVICES
Our Services
Strategic Advice
MORSE HTA Strategic Advice
Analyses
Advisory Boards
MORSE Advisory Panel (MAP)
Training
Private Payer
Negotiation Simulation
Reimbursement Training
Reports
Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
Oncology and Biosimilar Sub-Report
NEWS
MORSE Signals
MORSE Wire
Publications
What’s New
EVENTS
LINKS
CONTACT US
HOME
ABOUT MORSE
The Team
Strategic Partners
Lorraine Boyle
Dominika Dabrowski
Stephen Filbey
Brent Korte
Careers
SERVICES
Our Services
Strategic Advice
MORSE HTA Strategic Advice
Analyses
Advisory Boards
MORSE Advisory Panel (MAP)
Training
Private Payer
Negotiation Simulation
Reimbursement Training
Reports
Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
Oncology and Biosimilar Sub-Report
NEWS
MORSE Signals
MORSE Wire
Publications
What’s New
EVENTS
LINKS
CONTACT US
CADTH
All the posts published.
Number of Active Negotiations (49) at Highest Level Since November 2018
July 7, 2019
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
BC Pharmacare Now Transitioning Patients on Copaxone® to GLATECT™
November 29, 2018
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
Significant Developments in Canadian Drugs for Rare Disease Policy
November 14, 2018
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
Presidents’ Roundtable – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty
November 8, 2018
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
Summary of the CADTH Drug Portfolio Information Session Nov. 2018
November 7, 2018
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
Has RWE in Canada Reached a Tipping Point?
October 23, 2018
-
Market Access News
-
Posted by
Lorraine Boyle
Read More →
Read More →
HTA Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty
October 18, 2018
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
Summary of the HC-HTA Alignment Webinar Sept. 2018
October 17, 2018
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
PE Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty
October 11, 2018
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
CADTH & INESSS Pilot Project: Joint Engagement with Clinical Specialists
September 14, 2018
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
MORSE Consulting Proudly Participates at the 2018 CADTH Symposium
April 12, 2018
-
Market Access News
,
What's New
-
Posted by
MORSE Team
Read More →
Read More →
A Comparison of Proposed INESSS and Current CADTH Evaluation Fees
March 6, 2018
-
Market Access News
-
Posted by
MORSE Team
Read More →
Read More →
Cornerstone Research Group and MORSE Consulting form a Strategic Partnership
February 7, 2018
-
Market Access News
,
What's New
-
Posted by
MORSE Team
Read More →
Read More →
Health Technology Assessment Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada
August 10, 2017
-
Publications
-
Posted by
MORSE Team
Read More →
Read More →
Introducing the MORSE WIRE – Live market access news and trends at your finger tips
June 22, 2017
-
Market Access News
,
What's New
-
Posted by
MORSE Team
Read More →
Read More →
Older posts
Newer posts
CADTH - Info and details on - Page 4 of 5 - MORSE Consulting Inc.
Private
Public
Private
INESSS
CADTH
HTA
pCPA
Public Payers
Health Canada
Patients
Private Payers
PMPRB
Public
INESSS
CADTH
HTA
pCPA
Public Payers
Health Canada
Patients
Private Payers
PMPRB
Public
Private
Public
INESSS
CADTH
HTA
pCPA
Public Payers
Health Canada
Patients
Private Payers
PMPRB
Private
INESSS
CADTH
HTA
pCPA
Public Payers
Health Canada
Patients
Private Payers
PMPRB